Human papilloma virus (HPV) is one of the leading causes of cervical cancer and genital warts. In 2006, Merck & Co received approval for a vaccine against HPV known as Gardasil. Vaccine was heavily promoted by the Department of Health and Human Services launched a huge push to vaccinate girls as young as 13. By the end of 2007 nearly 25% of girls ages 13 to 17 had received the Gardasil vaccination. In 2009, the HHS launched a second campaign to start vaccinating boys as young as 13 years of age to prevent genital warts caused by the human papilloma virus.
In 2007 GlaxoSmithKline applied for approval for their HPV vaccine known as Cervarix. In the US they received approval in 2009 and they began to compete with Merck & Co or the billion-dollar industry of vaccinating teenage girls and boys throughout the United States.
Many groups opposed the vaccinations for reasons ranging from the cost to safety reasons and ethical reasons. Some believe that making the HPV vaccine available in public schools was another way of condoning sexual activity among teens. The lack of a proper testing time was also a concern among many. According to report in the Annals of Medicine:
“For example, while the world’s leading medical authorities state that HPV vaccines are an important cervical cancer prevention tool, clinical trials show no evidence that HPV vaccination can protect against cervical cancer… Future vaccination policies should adhere more rigorously to evidence-based medicine and ethical guidelines for informed consent.”
Those who question the safety of the HPV vaccine are starting to see a number of cases that support their cause. To date there are 200 claims that have been filed against the HHS their injuries (191) or deaths (9) related to the vaccine. According to Judicial Watch HHS has awarded $5,877,710 to 49 victims to file claims, 47 for injuries and two for deaths. The compensation is being paid through the National Vaccine Injury Compensation Program (VICP), which amounts to $120,000 per claim.
So far, VICP has dismissed 59 claims, of which 57 were for injuries and 2 were for deaths. There are still 92 claims pending against the HHS for the HPV vaccination. Of those 92 claims 87 are for injuries and 5 for deaths.
In lieu of the number of incidents involving HPV vaccines, Tom Fitton, President of Judicial Watch commented:
“This new information from the government shows that the serious safety concerns about the use of Gardasil have been well-founded. Public health officials should stop pushing Gardasil on children.”
I agree with Fitton in warning anyone who has a teenaged daughter or son concerning giving them the HPV vaccine. The medical evidence does not support the claims of the manufacturers. The claims filed against the HHS should raise a red flag and cause one to question the necessity of submitting one’s child to the potential dangers of being vaccinated.